Opinion

Pill side effect is no cause for complaint

Was I alone in being delighted by your article, 'Galliard lands Pfizer UK brief for Revatio launch (Healthcare News, 21 October)? It stated: 'Unwanted erections were not a problem (in the trial) as most patients were female' and 'no male alerted organisers to their having an unrequired erection.' 'Unrequired' - what a marvellous term, unheard of to most males!

November 11, 2005

Mark Madsen, Madsen Consulting Associates.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Up next:

Ford plays up largest single investment in its history with community focus

Ford plays up largest single investment in its history with community focus

TikTok unveils fresh ad products, measurement and brand safety tools

Eva Kemp has joined Precision Strategies as a VP on the firm's paid media team.

Precision Strategies hires White House alum Eva Kemp as VP on its paid media team

The Trevor Project rebrands for the next LGBTQ generation

The Trevor Project rebrands for the next LGBTQ generation

PodMatch releases project management software, PodcastSOP

PodMatch releases project management software, PodcastSOP

UpHealth names Ketchum AOR

UpHealth names Ketchum AOR

The internet reacts to Health Canada’s rebranding of COVID-19 vaccine names

The internet reacts to Health Canada’s rebranding of COVID-19 vaccine names

This morning's news to know.

Breakfast Briefing: 5 things for PR pros to know on Tuesday morning

Archetype owner Next 15's pre-tax profit surges 69 per cent in H1

Archetype owner Next 15's pre-tax profit surges 69 per cent in H1

Phil Elwood joins Ogilvy as North America MD of corporate media and issues

Phil Elwood joins Ogilvy as North America MD of corporate media and issues